1188 related articles for article (PubMed ID: 8899312)
21. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
22. Multiple tumoricidal effector mechanisms induced by adriamycin.
Salazar D; Cohen SA
Cancer Res; 1984 Jun; 44(6):2561-6. PubMed ID: 6327018
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
[TBL] [Abstract][Full Text] [Related]
24. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
25. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
[TBL] [Abstract][Full Text] [Related]
26. Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo.
Li H; Cao MY; Lee Y; Benatar T; Lee V; Feng N; Gu X; Liu P; Jin H; Wang M; Der S; Lightfoot J; Wright JA; Young AH
Int Immunopharmacol; 2007 Oct; 7(10):1350-9. PubMed ID: 17673150
[TBL] [Abstract][Full Text] [Related]
27. Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host.
Bhattacharyya N; Pal A; Patra S; Haldar AK; Roy S; Ray M
Int Immunopharmacol; 2008 Nov; 8(11):1503-12. PubMed ID: 18617020
[TBL] [Abstract][Full Text] [Related]
28. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
29. The effect of monotherapy and combined therapy with NSC-631570 (ukrain) on growth of low- and high-metastasizing B16 melanoma in mice.
Skivka L; Susak Y; Trompak O; Kudryavets Y; Bezdeneznikh N; Semesiuk N; Lykhova O
J Oncol Pharm Pract; 2011 Dec; 17(4):339-49. PubMed ID: 20817651
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
31. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
Boyko VN; Zholus RB
Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
[TBL] [Abstract][Full Text] [Related]
32. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
[TBL] [Abstract][Full Text] [Related]
33. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
[TBL] [Abstract][Full Text] [Related]
34. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
35. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
36. Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications.
Jin YM; Nowicky JW; Liepins A
Drugs Exp Clin Res; 1996; 22(3-5):99-101. PubMed ID: 8899311
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice.
DiNapoli MR; Calderon CL; Lopez DM
J Immunol; 1997 Feb; 158(4):1810-7. PubMed ID: 9029120
[TBL] [Abstract][Full Text] [Related]
39. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
40. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
